The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016
Jump to:
Preferred Name

irinotecan
Synonyms

(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate

C33H38N4O6
ID

http://purl.obolibrary.org/obo/dinto_DB00762
AHFScode

10:00.00
ATCCode

L01XX19
binds

http://purl.obolibrary.org/obo/dinto_2656

http://purl.obolibrary.org/obo/dinto_1972

http://purl.obolibrary.org/obo/dinto_3185

http://purl.obolibrary.org/obo/dinto_2019

http://purl.obolibrary.org/obo/dinto_0901

http://purl.obolibrary.org/obo/dinto_0217

http://purl.obolibrary.org/obo/dinto_0470

http://purl.obolibrary.org/obo/dinto_2990

http://purl.obolibrary.org/obo/dinto_0265

http://purl.obolibrary.org/obo/dinto_3568

http://purl.obolibrary.org/obo/dinto_1956

http://purl.obolibrary.org/obo/dinto_0276

http://purl.obolibrary.org/obo/dinto_0465

http://purl.obolibrary.org/obo/dinto_1754

http://purl.obolibrary.org/obo/dinto_0887

http://purl.obolibrary.org/obo/dinto_0883

http://purl.obolibrary.org/obo/dinto_1440

http://purl.obolibrary.org/obo/dinto_2828
CASRN

100286-90-6
DBBrand

camptosar
DBSalt

irinotecan hydrochloride
DBSynonym

cpt-11

camptothecin-11
Definition

Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. It is a derivative of camptothecin that inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex, and causes double-strand DNA breakage and cell death. It is a derivative of camptothecin.
has effect

http://purl.obolibrary.org/obo/OAE_0000388

http://purl.obolibrary.org/obo/OAE_0000497

http://purl.obolibrary.org/obo/OAE_0000453

http://purl.obolibrary.org/obo/OAE_0001373

http://purl.obolibrary.org/obo/OAE_0000827

http://purl.obolibrary.org/obo/OAE_0001154

http://purl.obolibrary.org/obo/OAE_0000377

http://purl.obolibrary.org/obo/OAE_0000831

http://purl.obolibrary.org/obo/OAE_0000318

http://purl.obolibrary.org/obo/OAE_0000391

http://purl.obolibrary.org/obo/OAE_0000218

http://purl.obolibrary.org/obo/OAE_0000198

http://purl.obolibrary.org/obo/OAE_0000825

http://purl.obolibrary.org/obo/OAE_0001431

http://purl.obolibrary.org/obo/OAE_0000913

http://purl.obolibrary.org/obo/OAE_0001449

http://purl.obolibrary.org/obo/OAE_0000415

http://purl.obolibrary.org/obo/OAE_0000195

http://purl.obolibrary.org/obo/OAE_0000545

http://purl.obolibrary.org/obo/OAE_0000021

http://purl.obolibrary.org/obo/OAE_0001448

http://purl.obolibrary.org/obo/OAE_0001095

http://purl.obolibrary.org/obo/OAE_0000660

http://purl.obolibrary.org/obo/OAE_0000382

http://purl.obolibrary.org/obo/OAE_0001165

http://purl.obolibrary.org/obo/OAE_0000600

http://purl.obolibrary.org/obo/OAE_0000310

http://purl.obolibrary.org/obo/OAE_0001365

http://purl.obolibrary.org/obo/OAE_0000608

http://purl.obolibrary.org/obo/OAE_0000403

http://purl.obolibrary.org/obo/OAE_0000454

http://purl.obolibrary.org/obo/OAE_0000632

http://purl.obolibrary.org/obo/OAE_0001146

http://purl.obolibrary.org/obo/OAE_0000601

http://purl.obolibrary.org/obo/OAE_0001340

http://purl.obolibrary.org/obo/OAE_0000551

http://purl.obolibrary.org/obo/OAE_0000943

http://purl.obolibrary.org/obo/OAE_0000084

http://purl.obolibrary.org/obo/OAE_0000434

http://purl.obolibrary.org/obo/OAE_0001200

http://purl.obolibrary.org/obo/OAE_0001068

http://purl.obolibrary.org/obo/OAE_0000400

http://purl.obolibrary.org/obo/OAE_0000086

http://purl.obolibrary.org/obo/OAE_0000584

http://purl.obolibrary.org/obo/OAE_0001129

http://purl.obolibrary.org/obo/OAE_0002206

http://purl.obolibrary.org/obo/OAE_0000414

http://purl.obolibrary.org/obo/OAE_0000038

http://purl.obolibrary.org/obo/OAE_0000034

http://purl.obolibrary.org/obo/OAE_0002122

http://purl.obolibrary.org/obo/OAE_0000460

http://purl.obolibrary.org/obo/OAE_0001145

http://purl.obolibrary.org/obo/OAE_0000866

http://purl.obolibrary.org/obo/OAE_0000401

http://purl.obolibrary.org/obo/OAE_0000536

http://purl.obolibrary.org/obo/OAE_0000898

http://purl.obolibrary.org/obo/OAE_0000647

http://purl.obolibrary.org/obo/OAE_0000185

http://purl.obolibrary.org/obo/OAE_0000468

http://purl.obolibrary.org/obo/OAE_0000602

http://purl.obolibrary.org/obo/OAE_0000421

http://purl.obolibrary.org/obo/OAE_0001217

http://purl.obolibrary.org/obo/OAE_0000396

http://purl.obolibrary.org/obo/OAE_0000362

http://purl.obolibrary.org/obo/OAE_0000374

http://purl.obolibrary.org/obo/OAE_0000394

http://purl.obolibrary.org/obo/OAE_0000211

http://purl.obolibrary.org/obo/OAE_0000358

http://purl.obolibrary.org/obo/OAE_0001035

http://purl.obolibrary.org/obo/OAE_0000618

http://purl.obolibrary.org/obo/OAE_0000456

http://purl.obolibrary.org/obo/OAE_0001366

http://purl.obolibrary.org/obo/OAE_0000534

http://purl.obolibrary.org/obo/OAE_0001364

http://purl.obolibrary.org/obo/OAE_0000402

http://purl.obolibrary.org/obo/OAE_0001298

http://purl.obolibrary.org/obo/OAE_0000350
has pharmacological target

http://purl.obolibrary.org/obo/dinto_2656

http://purl.obolibrary.org/obo/dinto_3185
InChI

InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1
InChIKey

InChIKey=UWKQSNNFCGGAFS-XIFFEERXSA-N
inhibits

http://purl.obolibrary.org/obo/dinto_2656

http://purl.obolibrary.org/obo/dinto_1972

http://purl.obolibrary.org/obo/dinto_3185

http://purl.obolibrary.org/obo/dinto_2019

http://purl.obolibrary.org/obo/dinto_0901
is metabolised by

http://purl.obolibrary.org/obo/dinto_0470

http://purl.obolibrary.org/obo/dinto_2990

http://purl.obolibrary.org/obo/dinto_0265

http://purl.obolibrary.org/obo/dinto_0901

http://purl.obolibrary.org/obo/dinto_3568

http://purl.obolibrary.org/obo/dinto_1956

http://purl.obolibrary.org/obo/dinto_0276

http://purl.obolibrary.org/obo/dinto_0465

http://purl.obolibrary.org/obo/dinto_1754
is substrate of

http://purl.obolibrary.org/obo/dinto_0217

http://purl.obolibrary.org/obo/dinto_0470

http://purl.obolibrary.org/obo/dinto_2990

http://purl.obolibrary.org/obo/dinto_0265

http://purl.obolibrary.org/obo/dinto_0901

http://purl.obolibrary.org/obo/dinto_3568

http://purl.obolibrary.org/obo/dinto_1956

http://purl.obolibrary.org/obo/dinto_0276

http://purl.obolibrary.org/obo/dinto_0465

http://purl.obolibrary.org/obo/dinto_1754

http://purl.obolibrary.org/obo/dinto_0887

http://purl.obolibrary.org/obo/dinto_0883

http://purl.obolibrary.org/obo/dinto_1440

http://purl.obolibrary.org/obo/dinto_2828
is transported by

http://purl.obolibrary.org/obo/dinto_0887

http://purl.obolibrary.org/obo/dinto_0883

http://purl.obolibrary.org/obo/dinto_1440

http://purl.obolibrary.org/obo/dinto_2828
label

irinotecan
may interact with

http://purl.obolibrary.org/obo/CHEBI_71219

http://purl.obolibrary.org/obo/CHEBI_8107

http://purl.obolibrary.org/obo/CHEBI_37924

http://purl.obolibrary.org/obo/CHEBI_499361

http://purl.obolibrary.org/obo/dinto_DB04572

http://purl.obolibrary.org/obo/dinto_DB00582

http://purl.obolibrary.org/obo/dinto_DB00072

http://purl.obolibrary.org/obo/dinto_DB01320

http://purl.obolibrary.org/obo/dinto_DB01026

http://purl.obolibrary.org/obo/CHEBI_68647

http://purl.obolibrary.org/obo/dinto_DB00976
prefixIRI

obo2:dinto_DB00762
prefLabel

irinotecan
SMILES

CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=C1C=C(OC(=O)N1CCC(CC1)N1CCCCC1)C=C2
Synonym

(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate

C33H38N4O6
xref

PubChem Substance:46505871

ChemSpider:54825

Wikipedia:http://en.wikipedia.org/wiki/Irinotecan

Drugs.com:http://www.drugs.com/cdi/irinotecan.html

Drugs Product Database (DPD):2231622

National Drug Code Directory:0703-4432-11

PubChem Compound:60838

PharmGKB:PA450085

RxList:http://www.rxlist.com/cgi/generic2/irinot.htm
subClassOf

http://purl.obolibrary.org/obo/dinto_000055
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_80630 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 OBA LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62040 NCIT LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62040 ROO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0123931 OCHV LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000022032 NDFRT LOOM
http://www.drugbank.ca/drugs/DB00762 FTC LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_80630 DDSS LOOM
https://go.drugbank.com/drugs/DB00762 MDM LOOM
http://purl.bioontology.org/ontology/RXNORM/51499 RXNORM LOOM
http://purl.bioontology.org/ontology/MESH/D000077146 MESH LOOM
http://www.co-ode.org/ontologies/galen#Irinotecan GALEN LOOM
http://www.phoc.org.cn/pmo/class/PMO_00026193 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/ATC/L01CE02 ATC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C051890 RH-MESH LOOM
http://purl.bioontology.org/ontology/CSP/4009-0014 CRISP LOOM
http://purl.bioontology.org/ontology/VANDF/4024027 VANDF LOOM
http://purl.bioontology.org/ontology/NDDF/005262 NDDF LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#16325 OCHV LOOM
http://purl.obolibrary.org/obo/NCIT_C62040 BERO LOOM
http://purl.jp/bio/4/id/200906060658722270 IOBC LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/372538008 SNOMEDCT LOOM
http://stirdf.jst.go.jp/id/200907064751838008 IOBC LOOM